Blakemore K J, Qin N G, Petrie R H, Paine L L
Department of Obstetrics and Gynecology, Washington University School of Medicine.
Obstet Gynecol. 1990 May;75(5):757-61.
Fifty-two women undergoing labor induction and vaginal delivery at term were randomized between two oxytocin infusion protocols, involving hourly versus quarter-hourly increases in dose. Potential differences were sought of duration of labor, amount of uterine activity generated, and amount of oxytocin required. Starting at 0.5 mU/minute, oxytocin infusion was increased regularly in small increments every hour or every 15 minutes, according to group assignment. No differences were observed in potentially confounding clinical and demographic factors between the groups, including time to ruptured membranes. There were no clinically or statistically significant differences found for the duration of any phase or stage of labor, quantitative assessment of uterine activity, incidence of hyperstimulation, or neonatal outcome. The average dose of oxytocin used was lower in the hourly than in the quarter-hourly, protocol (4.4 versus 6.7 mU/minute; P less than .005). Significantly fewer patients on the hourly protocol required a maximum infusion rate exceeding 8 mU/minute (P less than .05). More patients on the hourly protocol either had oxytocin discontinued completely or were maintained at 4 mU/minute or less during the active phase of labor (P less than .05 and P less than .001, respectively). We conclude that a slower rate of increase in oxytocin administration via continuous infusion results in no prolongation of any phase of induced labor, while permitting lower infusion rates of the drug.
52名足月接受引产和阴道分娩的女性被随机分为两种催产素输注方案组,剂量增加分别为每小时一次和每15分钟一次。研究了产程持续时间、产生的子宫活动量以及所需催产素量的潜在差异。根据分组,催产素输注从0.5 mU/分钟开始,每小时或每15分钟以小剂量定期增加。两组间在可能产生混淆的临床和人口统计学因素方面未观察到差异,包括破膜时间。在产程的任何阶段或时期的持续时间、子宫活动的定量评估、子宫过度刺激的发生率或新生儿结局方面,均未发现临床或统计学上的显著差异。每小时方案组使用的催产素平均剂量低于每15分钟方案组(4.4对6.7 mU/分钟;P<0.005)。每小时方案组中需要最大输注速率超过8 mU/分钟的患者明显较少(P<0.05)。在产程活跃期,每小时方案组中更多患者要么完全停用催产素,要么维持在4 mU/分钟或更低水平(分别为P<0.05和P<0.001)。我们得出结论,通过持续输注较慢增加催产素给药速率不会导致引产任何阶段的延长,同时允许较低的药物输注速率。